Related Experiment Video
Updated: Jun 23, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy
Yelda A Leal1, Alejandro Gómez, Armando Madrazo-de la Garza
1Unidad de Investigación Médica, Unidad Médica de Alta Especialidad del Centro Médico Nacional "Ignacio García Téllez" IMSS Mérida, Yucatán. yelda_leal@hotmail.com
Insights
A primary Helicobacter pylori infection offers no significant protection against reinfection in children. This study found similar infection rates in both previously uninfected and eradicated children over two years.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Immunology
Background:
- Helicobacter pylori infection is a common childhood infection globally.
- The protective effect of a primary H. pylori infection against subsequent reinfection in children remains unclear.
- Understanding reinfection dynamics is crucial for managing this prevalent pathogen.
Purpose of the Study:
- To investigate the protective immunity conferred by a primary Helicobacter pylori infection against reinfection in pediatric populations.
- To compare the incidence of new H. pylori infections in children with no prior infection versus those who were successfully treated.
Main Methods:
- A 2-year follow-up study involving 120 children, divided into a primo-infection cohort (n=80) and a reinfection cohort (n=40).
- Urea breath tests (UBT) were administered every 3-6 months to detect H. pylori acquisition.
- Statistical analysis, including chi-squared tests and survival curves, compared infection and reinfection rates and evaluated risk factors.
Main Results:
- No significant difference was observed in primo-infection rates (21.2%) versus reinfection rates (25%).
- Most primo-infections occurred within the first year, while reinfections were more common in the second year.
- The majority of H. pylori infections in both cohorts were transient, with similar risk factors identified.
Conclusions:
- A prior Helicobacter pylori infection does not provide substantial protection against reinfection in the studied pediatric cohort.
- The findings suggest that immunity following initial H. pylori infection may be short-lived or incomplete in children.
- Further research is needed to elucidate the immunological mechanisms influencing H. pylori reinfection in children.
Background:
Helicobacter pylori infection is one of the most common chronic infections in the world, and is acquired mainly during childhood. It is not clear to which extent a primary infection protects the child from reinfection. Our aim was to determine the possible protection conferred by a primary infection against H. pylori reinfection in children.
Methods:
A follow-up study with 120 children distributed in two cohorts; the first included 80 children without previous H. pylori infection (primo-infection cohort); the second included 40 infected children successfully eradicated (reinfection cohort). Cohorts were monitored during 2 years with urea-breath-test (UBT) at 3, 6, 9, 12, 18 and 24 months for the acquisition of H. pylori infection. We compared the rate of reinfection in eradicated children with the rate of infection in children without previous infection. H. pylori infection during the follow-up was analyzed and compared between cohorts using chi2 and survival curves. A questionnaire was performed for the evaluation of possible risk factors for infection in both cohorts.
Results:
No significant differences in rates of primo-infection or reinfection were found; 17 (21.2%) primo-infections and 10 (25%) reinfections were documented. Most of the primo-infections (14/17) occurred in the first year of follow-up. In contrast, reinfection episodes occurred more frequently during the second year (6/10). In both cohorts, most infections were transient. Risk factors were similar for both, primo and reinfection cohorts.
Conclusion:
A primary infection does not protect from reinfection in the population of children studied.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.